IMDX
Insight Molecular Diagnostics Inc.
NASDAQ: IMDX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$3.83
-8.81% today
Updated 2026-04-29
Market cap
$123.53M
P/E ratio
—
P/S ratio
30.46x
EPS (TTM)
$-1.65
Dividend yield
—
52W range
$2 – $9
Volume
0.3M
Insight Molecular Diagnostics Inc. (IMDX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |